Create account

Coverage dated May 2, 2022

Pfizer sees high demand for Covid-19 pill as profits jump

Headline from Digital Journal

Pfizer executives said Tuesday they are confident of strong demand for the company's Covid-19 antiviral treatment amid easing pandemic rules as the big

Digital Journal's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

5 articles, oldest first.

  1. Digital Journal

    Pfizer sees high demand for Covid-19 pill as profits jump (opens Digital Journal)

    Published

    Digital Journal's feed description

    Pfizer executives said Tuesday they are confident of strong demand for the company's Covid-19 antiviral treatment amid easing pandemic rules as the big

  2. France 24

    Pfizer Q1 revenues jump 77% to $25.7 bn on Covid-19 vaccine (opens France 24)

    Published

    France 24's feed description

    Pfizer reported another quarter of huge revenues growth because of its Covid-19 vaccine on Tuesday, but lowered the company's full-year profit forecast due in part to shifts in foreign exchange.

  3. The Guardian

    Pfizer accused of Covid profiteering as first-quarter sales hit $26bn (opens The Guardian)

    Published

    The Guardian's feed description

    Pharma firm criticised over pricing and for keeping monopoly control over vaccine and new Paxlovid pill

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Pfizer sees high demand for Covid-19 pill as profits jump | Since Then